Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technologyRUTHERFORD, N.J., Feb. 26, 2025 (GLOBE ...
according to Glucotrack. Given the severe health risks, glucose monitoring is non-negotiable for many people with diabetes. Some rely on traditional fingerstick blood glucose monitors, which only ...
The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...
Goode, PhD, President & Chief Executive Officer of Glucotrack. “With these positive results, the promise of continuous blood glucose monitoring is one step closer to reality.” The prospective ...
(Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Guillermo Umpierrez, MD, CDCES, ...
Continuous Glucose Monitors Can Overestimate Blood Sugar Levels, Study Finds By Dennis Thompson HealthDay Reporter TUESDAY, March 4, 2025 (HealthDay News) -- Continuous blood glucose monitors have ...
Although this initial study was not intended to measure sensor accuracy, Glucotrack noted that the system performed as expected, delivering results in line with preclinical animal studies. This ...
Goode, PhD, President & Chief Executive Officer of Glucotrack. "With these positive results, the promise of continuous blood glucose monitoring is one step closer to reality." The prospective ...
Dr. Umpierrez said: "I am honored to be joining Glucotrack’s Medical Advisory Board. The Company's innovative approach to continuous blood glucose monitoring through its implantable CBGM ...
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technologyRUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) ...
The monitors consistently overestimated blood sugar levels compared with finger prick tests The monitors overestimated, by two- to four-fold, the amount of time people spent with excessive blood ...